About DuKang
Pharmaceuticals, Inc.
DuKang Pharmaceuticals Inc. (DK Pharma) is a company focusing on the following fields:
505 (b)(2) new drug for NDA. Improving the drug delivery system and the patient compliance.
Fast-pacing clinical development based on targeting precise population.
DK Pharma is operating with a lean project management style without labs and factories. We collaborates with our partners for product developments.
Management Team
Chih-Ming Chen Ph.D.
Founder
Chih-Ming Chen Ph.D.
Founder
Dr. Chen is Founder and Chairman of DuKang Pharmaceuticals. He is also Founder, Chairman, and President of TWi Pharmaceuticals, which was sold to Bora Pharmaceuticals in 2022. In 2003, Dr. Chen founded Anchen Pharmaceuticals in Irvine, California which was acquired by Par Pharmaceutical in 2011. Prior to Anchen, he was co-Founder and President of Andrx Pharmaceuticals which was acquired by Watson in 2006. He also worked at Bristol Laboratories, Berlex Laboratories, and IVAX, playing a leading role in R&D from 1982 to 1992. Dr. Chen received his Ph.D. in Pharmaceutics/ Pharmaceutical Chemistry from Ohio State University and his M.S. and B.S. from the School of Pharmacy, National Taiwan University.